medigraphic.com
ISSN 1561-2937 (Impreso)

2021, Número 4

<< Anterior Siguiente >>

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (4)


Seguimiento clínico a largo plazo de la angioplastia con stent en el anciano.

García-Porrero E, Rivas EE, Andrade RM, Vicente VT

Idioma: Español
Referencias bibliográficas: 38
Paginas: 1-13
Archivo PDF: 540.28 Kb.


RESUMEN

La enfermedad cardiovascular (ECV) ha sido la principal causa de muerte entre las personas mayores en los países avanzados. Además, la cardiopatía isquémica ha sido una patología típica de los pacientes ancianos. Si bien la angioplastia con stent se considera un procedimiento eficaz y seguro para los pacientes cardíacos mayores de 65 años, la información sobre el seguimiento clínico a largo plazo de los pacientes ancianos sometidos a angioplastia con stent es escasa.
El objetivo de este estudio fue aumentar el conocimiento sobre la evolución a largo plazo de los pacientes mayores de 65 años, que requirieron angioplastia con Stent, mediante el desarrollo de un estudio de cohorte, analítico, observacional y prospectivo.
Entre junio de 1991 y junio de 1997, se incluyó en el estudio a un total de 1029 pacientes consecutivos. Los pacientes estaban en dos grupos: mayores de 65 años y menores de 65 años. La incidencia de eventos clínicos a largo plazo (4 años) es similar. Aunque se detecta una mayor tasa de mortalidad (65% más alta) en pacientes ancianos.
El estudio permite conocer mejor la evolución a largo plazo de los pacientes mayores de 65 años. Es importante destacar que la angioplastia con stent logra resultados satisfactorios a medio plazo en pacientes de edad avanzada.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Olshansky SJ, Ault AB. The Fourth Stage of the Epidemiologic Transition: The Age of Delayed Degenerative Diseases. The Milbank Quarterly 1986;64(3): 355–91

  2. Mackenbach JP. The Rise and Fall of Diseases: Reflections on the History of Population Health in Europe since ca. 1700. Europ J Epidemiol, 2021; February 20, https://doi.org/10.1007/s10654-021-00719-7

  3. Vandenbroucke JP. Johan P. Mackenbach. A History of Population Health: Rise and Fall of Disease in Europe : Clio Medica, Volume 101. Brill/Rodopi 2020; https://doi.org/10.1163/9789004429130. Europ J Epidemiol 2021; february 18, https://doi.org/10.1007/s10654-021-

  4. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart Disease and Stroke Statistics--2011 Update: A Report from the American Heart Association. Circulation 2011; 123(4): e18–209 https://doi.org/10.1161/CIR.0b013e3182009701

  5. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive Summary: Heart Disease and Stroke Statistics--2013 Update: A Report from the American Heart Association. Circulation 2013;127(1),143–52 https://doi.org/10.1161/CIR.0b013e318282ab8f

  6. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Jarett D. Berry JD et al. Heart Disease and Stroke Statistics--2013 Update: A Report from the American Heart Association. Circulation 2013;127(1):e6–245. https://doi.org/10.1161/CIR.0b013e31828124ad

  7. Showkathali R, Natarajan A. Antiplatelet and Antithrombin Strategies in Acute Coronary Syndrome: State-of-the-Art Review. Current Cardiology Reviews 2012;8(3):239–49. https://doi.org/10.2174/157340312803217193

  8. Maheedhar G, Khan M, Jonsson O. Heart Failure. South Dakota Medicine: The Journal of the South Dakota State Medical Association 2015;68(9), 403–5, 407–9

  9. Ruano-Ravina A, Pena-Gil C, Abu-Assi E, Raposeiras S, van ’t Hof A, Esther Meindersma E et al. Participation and Adherence to Cardiac Rehabilitation Programs. A Systematic Review. Int J Cardiol 2016;223;436–43. https://doi.org/10.1016/j.ijcard.2016.08.120

  10. Rivas Estany E, García Porrero E, Andrade Ruiz M. Modelos de Unidades de Prevención Cardiovascular Integral, con especial énfasis en el papel preventivo de la Rehabilitación Cardíaca. Rev Cubana Cardiol Cir Cardiovasc 2016; 22(1): 34-42.

  11. Rivas Estany E, Campos Vera NA. ¿Cómo influye la rehabilitación cardíaca después de la cirugía coronaria y la angioplastia? Rev Cubana Cardiol Cir Cardiovasc. 2018;24(3): 290-296.

  12. Campos Vera N, Rivas Estany E, Hernández García S, Rodríguez Nande L, Castillo Diez E, Castillo Diez E, Andrade Ruiz H. Rehabilitación cardiovascular y su efecto en la calidad de vida luego de intervencionismo coronario percutáneo. Rev Cubana Cardiol Cir Cardiovasc 2019;25(1):86-97

  13. Rivas Estany E, Campos Vera N. Impact of Cardiac Rehabilitation in Patients after Myocardial Revascularization. Sports Med Rehabil J. 2019; 4(1): 1044

  14. Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D et al. Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients across 27 Countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V Registry. Europ J Prevent Cardiol 2019; 26 (8):824–35. https://doi.org/10.1177/2047487318825350

  15. Avilés FF, de la Fuente Galán L, Durán JM, Gimeno F, Ramos B, Alonso JJ et al. Angioplasty for acute coronary syndromes in the era of the stent. Rev Esp Cardiol 1999;52: Suppl 1:131–40

  16. Shirani J, Yousefi J, Roberts WC. Major Cardiac Findings at Necropsy in 366 American Octogenarians. Amer J Cardiol 1995;75(2):151–56 https://doi.org/10.1016/s0002-9149(00)80065-x

  17. Means, R. Public Policy and Older People--Where Are We Going? Journal of Social Policy 1987; 16(4): 543–50 https://doi.org/10.1017/s0047279400016160

  18. Daatland S O. Recent Trends and Future Prospects for the Elderly in Scandinavia. J Aging Social Policy 1994;6(1–2):181–97 https://doi.org/10.1300/J031v06n01_12

  19. Takeshi K, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial Angiographic Follow-up after Palmaz-Schatz Stent Implantation: Comparison with Conventional Balloon Angioplasty. J Amer Coll Cardiol 1993;21(7):1557–63 https://doi.org/10.1016/0735-1097(93)90368-B

  20. White C J. Wiktor Coronary Stent. Cardiol Clinics 1994;12(4):665–71.

  21. Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ et al. ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)-Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) Endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001;103(24),3019–41 https://doi.org/10.1161/01.cir.103.24.3019

  22. Cohen HA, Williams DO, David R. Holmes DR, Selzer F, Kip KE and NHLBI Dynamic Registry. Impact of Age on Procedural and 1-Year Outcome in Percutaneous Transluminal Coronary Angioplasty: A Report from the NHLBI Dynamic Registry. Amer Heart J 2003;146(3): 513–19 https://doi.org/10.1016/S0002-8703(03)00259-X.

  23. Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC et al and New York State Angioplasty Registry. Comparison of Outcomes of Percutaneous Coronary Interventions in Patients of Three Age Groups (<60, 60 to 80, and >80 Years) (from the New York State Angioplasty Registry). Amer J Cardiol 2006;98(10):1334–39. https://doi.org/10.1016/j.amjcard.2006.06.026

  24. Graham MM., Ghali WA, Faris PD, Galbraith DP, Norris CM, Knudtson ML, and Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Survival after Coronary Revascularization in the Elderly. Circulation 2002;105(20):2378–84. https://doi.org/10.1161/01.cir.0000016640.99114.3d

  25. Wennberg DE, Makenka DJ, Sengupta A, Lucas FL, Vaitkus PT, Quinton H, et al. Percutaneous Transluminal Coronary Angioplasty in the Elderly: Epidemiology, Clinical Risk Factors, and in-Hospital Outcomes. The Northern New England Cardiovascular Disease Study Group. Amer Heart J 1999; 137(4):639–45 https://doi.org/10.1016/s0002-8703(99)70216-4

  26. De Gregorio J, Kobayashi Y, Albiero R, Reimers B, Di Mario C, Finci L et al. Coronary Artery Stenting in the Elderly: Short-Term Outcome and Long-Term Angiographic and Clinical Follow-Up. J Amer Coll Cardiol 1998;32(3):577–83 https://doi.org/10.1016/s0735-1097(98)00287-3.

  27. Alfonso F, Azcona L, Perez-Vizcayno MJ, Hernandez R, Goicolea J, Fernandez-Ortiz A et al. Initial Results and Long-Term Clinical and Angiographic Implications of Coronary Stenting in Elderly Patients. Amer J Cardiol 1999; 83(10):1483–87, https://doi.org/10.1016/s0002-9149(99)00128-9

  28. Klein LW, Block P, Brindis RG, McKay CR, McCallister BD, Wolk M et al and ACC-NCDR Registry. Percutaneous Coronary Interventions in Octogenarians in the American College of Cardiology-National Cardiovascular Data Registry: Development of a Nomogram Predictive of in-Hospital Mortality. J Amer Coll Cardiol 2002;40(3):394–402 https://doi.org/10.1016/s0735-1097(02)01992-7

  29. Schwartz RS, Holmes DR, Topol EJ. The Restenosis Paradigm Revisited: An Alternative Proposal for Cellular Mechanisms. J Amer Coll Cardiol 1992;20(5): 1284–93 https://doi.org/10.1016/0735-1097(92)90389-5

  30. Forrester JS, Fishbein M, Helfant R, Fagin J. A Paradigm for Restenosis Based on Cell Biology: Clues for the Development of New Preventive Therapies. J Amer Coll Cardiol 1991;17(3):758–69 https://doi.org/10.1016/s0735-1097(10)80196-2.

  31. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, M. van den Brand M et al. Incidence of Restenosis after Successful Coronary Angioplasty: A Time-Related Phenomenon. A Quantitative Angiographic Study in 342 Consecutive Patients at 1, 2, 3, and 4 Months.” Circulation 1988;77(2):361–71 https://doi.org/10.1161/01.cir.77.2.361

  32. Chauhan MS, Kuntz RE, Ho KL, Cohen DJ, Popma JJ, Carrozza JP et al. Coronary Artery Stenting in the Aged. J Amer Coll Cardiol 2001;37(3):856–62 https://doi.org/10.1016/s0735-1097(00)01170-0

  33. Abizaid AS, Mintz GS, Abizaid A, Saucedo JF, Mehran R, Pichard AD et al. Influence of Patient Age on Acute and Late Clinical Outcomes Following Palmaz-Schatz Coronary Stent Implantation. Amer J Cardiol 2000;85(3):338–43 https://doi.org/10.1016/s0002-9149(99)00743-2

  34. Choussat R, Klersy C, Black AJ, Bossi I, Laurent JP, Jordan C. Long-Term (> or =8 Years) Outcome after Palmaz-Schatz Stent Implantation. Amer J Cardiol 2001; 88(1):10–16 https://doi.org/10.1016/s0002-9149(01)01577-6

  35. Stables, R. H. “Design of the ‘Stent or Surgery’ Trial (SoS): A Randomized Controlled Trial to Compare Coronary Artery Bypass Grafting with Percutaneous Transluminal Coronary Angioplasty and Primary Stent Implantation in Patients with Multi-Vessel Coronary Artery Disease.” Seminars in Interventional Cardiology: SIIC 4, no. 4 (December 1999): 201–7 https://doi.org/10.1006/siic.1999.0101.

  36. Yoshinobu O, Wykrzykowska JJ, Garg S, Vranckx P, Serruys PW and ARTS I and II Investigators. 5-Year Follow-up of Coronary Revascularization in Diabetic Patients with Multivessel Coronary Artery Disease: Insights from ARTS (Arterial Revascularization Therapy Study)-II and ARTS-I Trials. JACC. Cardiovascular Interventions 2011;4(3):317–23 https://doi.org/10.1016/j.jcin.2010.12.004.

  37. Rodriguez A, Boullon F, Perez-Baliño N, Paviotti C, Liprandi MI, Palacios LF. Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): In-Hospital Results and 1-Year Follow-up. ERACI Group. J Amer Coll Cardiol 1993;22(4): 1060–67. https://doi.org/10.1016/0735-1097(93)90416-x

  38. Nasser TK, Fry ET, Annan K, Khatib Y, Peters TF, VanTassel J, et al. Comparison of Six-Month Outcome of Coronary Artery Stenting in Patients <65, 65-75, and >75 Years of Age. Amer J Cardiol 1997;80(8):998–1001 https://doi.org/10.1016/s0002-9149(97)00592-4




2020     |     www.medigraphic.com